Home Authors Posts by Chris Anderson

Chris Anderson

95 POSTS 0 COMMENTS
Editor in Chief
Exome sequencing designed to identify the gene responsible for chronic kidney disease has a direct impact on treatment for most patients
News & Features

CareDx Gets Medicare Draft Coverage Decision for Heart Transplant Rejection Test

The NIH’s All of Us Research Program has awarded a total $28.6 million to establish three genome centers nationwide. In addition to producing genome data for researchers
News & Features

One Year After Launch, NIH’s All of Us Hits Key Milestones

News & Features

Precision for Medicine Broadens Biospecimen Offerings with ProMedDx, GLAS Acquisitions

Neuroblastoma cell line labeled with fluorescent molecules
News & Features

Potential Genetic Drug Target for Neuroblastoma Identified

News & Features

Gene-Pair Interactions May Predict Cancer Treatment Outcomes

Medical doctor touching virtual interface button of healthcare application
Bioinformatics

Syapse, Pfizer Ink Real-World Data Precision Oncology Collaboration

Facade of US Supreme court in Washington DC, United States of America
Magazine Editions

Whose Genes Anyway?: Congressional action on Section 101 of U.S. patent...

3D DNA strands on a technology abstract background
News & Features

Invitae Enhances Variant Interpretation Capabilities with Jungla Acquisition

NanoView Biosciences has closed on a $10 million Series B financing
Bioinformatics

GNS Healthcare Closes $23M Series D Finance Round

Bristol-Myers Squibb (BMS) plans to use Natera's Signatera custom circulating tumor DNA (ctDNA) assay in a Phase II study designed to assess the pharma giant’s cancer immunotherapy Opdivo (nivolumab) as an adjuvant treatment for non-small cell lung cancer (NSCLC). [Source: Eraxion/Getty]
News & Features

Biodesix to Acquire Oncimmune’s U.S. Operations

123...10Page 1 of 10

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up